Protalix BioTherapeutics (PLX) Deferred Taxes (2023 - 2026)
Protalix BioTherapeutics (PLX) posted Deferred Taxes of $71000.0 for Q2 2026, little changed on a QoQ basis from $71000.0 in Q1 2026, and down 69.26% year-over-year from $231000.0 in Q2 2025.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Deferred Taxes (2023 - 2026) Analysis & Trends
Protalix BioTherapeutics has reported Deferred Taxes for 4 years, with the latest figure at $71000.0 in Q2 2026.
- On a quarterly basis, Deferred Taxes fell 69.26% year-over-year to $71000.0 in Q2 2026; TTM through Jun 2026 was $364000.0, a 35.12% decrease from a year earlier, with the FY2025 full-year figure at $340000.0, up 44.07% from the prior year.
- Deferred Taxes was $71000.0 for Q2 2026 at Protalix BioTherapeutics, roughly flat from $71000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $443000.0 in Q3 2024, with the low at -$3.1 million in Q2 2023.
- Average Deferred Taxes over 4 years is -$215818.2, with a median of $59000.0 recorded in 2025.
- The sharpest annual moves came in 2024 and 2025: Deferred Taxes soared 1065.79% in 2024, then sank 86.68% in 2025.
- Over 4 years, Deferred Taxes stood at $38000.0 in 2023, then jumped by 1065.79% to $443000.0 in 2024, then slumped by 63.21% to $163000.0 in 2025, then tumbled by 56.44% to $71000.0 in 2026.
- The last three Deferred Taxes figures came in at $71000.0 (Q2 2026), $71000.0 (Q1 2026), and $163000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | -291.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -587.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -69.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 194.40 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 2.66 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -27.60 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Protalix BioTherapeutics | 218.36 Mn | 177.71 Mn | 12.13 Mn | 71,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 71,000.00 |
| Mar 31, 2026 | 71,000.00 |
| Dec 31, 2025 | 163,000.00 |
| Sep 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 231,000.00 |
| Mar 31, 2025 | -113,000.00 |
| Sep 30, 2024 | 443,000.00 |
| Jun 30, 2024 | -69,000.00 |
| Mar 31, 2024 | -138,000.00 |
| Sep 30, 2023 | 38,000.00 |
| Jun 30, 2023 | -3.13 Mn |